Research focus
About the research
How can new drugs for tuberculosis be found by the Institute for Tuberculosis Research led by Scott Gary Franzblau?
Read the full research overview
Scott Gary Franzblau is the Director of the Institute for Tuberculosis Research and the Albert Schatz Professor of Medicinal Chemistry and Pharmacognosy. The institute pursues large scale screening of both natural and synthetic compounds for those that demonstrate specificity of activity. Lead compounds are then optimized by semi-synthesis. Activity of all lead compounds is assessed in macrophage and mouse models of TB.
Selected publications
3 listedDiscovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent
Bioorganic & Medicinal Chemistry Letters
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis
Toxicology in Vitro
Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments
Journal of Natural Products
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings